TVTX earnings date and last-quarter result: last quarter miss, P/E -114.82. Updated 2026-07-23.
Travere Therapeutics (TVTX) Research Hub
Travere Therapeutics (TVTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 49.97 USD (-0.22%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -114.82, market cap 5.17B. This hub links to the full technical, earnings and options research available for TVTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 49.97 USD (-0.22%) |
| 52-week range | 49.24 USD – 68.73 USD |
| Trend regime | Range |
| 14-day RSI | 30.1 (Bearish) |
| Trailing P/E | -114.82 |
| Market cap | 5.17B |
| Dividend yield | 0.00% |
Available research for TVTX
Covered Call on TVTX: how it works, illustrative setup around the real 49.97 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TVTX: how it works, illustrative setup around the real 49.97 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TVTX: how it works, illustrative setup around the real 49.97 USD price, max profit/loss, breakeven and when to use it. Educational.
TVTX technical analysis: range, last 49.97 USD, RSI 30.1, 52w range 49.24 USD–68.73 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TVTX in?
Travere Therapeutics (TVTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TVTX in an uptrend or downtrend?
As of 2026-10-26, TVTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TVTX's trailing P/E ratio?
TVTX's trailing P/E is -114.82, with a market cap of 5.17B. See the earnings research page for full valuation detail.